🧪 證據引擎判讀
鋸棕櫚 對 雄性禿（雄性遺傳性禿髮） 真的有效嗎？
鋸棕櫚 對 雄性禿（雄性遺傳性禿髮） 有初步證據，但有重要 caveat 要注意。
鋸棕櫚 × 雄性禿（雄性遺傳性禿髮）
Saw Palmetto
少量 RCT 方向一致但樣本小；學會「may consider」
狀態：附警語發布
可發布但需顯示 caveat
綜合分數
55%
信心度
78%
效應方向
⬆
註記
⚠️ COI 🇹🇼
13 層證據快覽（點開展開）
| 來源 | 立場 | 信心 |
|---|---|---|
| 台灣市場 | neutral | 75% |
| 台灣法規 | cautious | 78% |
| PubMed (NIH) | weakly_supportive | 55% |
| 美國 FDA | cautious | 75% |
| EFSA 歐盟 | neutral | 80% |
| 英國 NHS | against | 90% |
| 食藥署 TFDA | cautious | 70% |
| 世界衛生組織 WHO | neutral | 70% |
| NIH ODS | cautious | 85% |
| Mayo Clinic 梅約診所 | neutral | 50% |
| Cleveland Clinic 克里夫蘭診所 | neutral | 50% |
| Harvard Health 哈佛健康 | neutral | 50% |
| 專業學會 | neutral | 50% |
| 藥物交互作用 | cautious | 75% |
關鍵引用（10）
- US FDA — 立場: cautious
「Saw palmetto is not the subject of an applicable USP or NF monograph, is not a component of an FDA-approved human drug, and does not appear on the 503A bulks list.」
來源 → - EU EFSA — 立場: neutral
「1,548 claims on 'botanicals' have been placed on hold by the Commission pending further consideration on how to proceed with these」
來源 → - UK NHS — 立場: against
「Your doctor should not offer you homeopathy, herbal treatments or acupuncture to treat urinary symptoms ... there is not enough reliable evidence about how well they work or how safe they are. ... [Saw palmetto] was no more effective than a…」
來源 → - TW TFDA / 衛福部 — 立場: cautious
「在台灣，鋸棕櫚這個成分目前還不能合法地加在食品裡面」
來源 → - WHO — 立場: neutral
「WHO monographs on selected medicinal plants - Volume 2」
來源 → - NIH Office of Dietary Supplements — 立場: cautious
「saw palmetto is probably not helpful for urinary tract symptoms associated with prostate enlargement in men. The evidence is too limited to allow conclusions to be reached [for male-pattern hair loss]. Serenoa repens, at two and three times…」
來源 → - PubMed PMID 12006122
「A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia」
來源 → - PubMed PMID 22735503
「Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study」
來源 → - PubMed PMID 27387994
「Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract」
來源 → - PubMed PMID 32553197
「Natural hair supplement: Friend or foe? Saw palmetto, a systematic review in alopecia」
來源 →
判讀產製方式
上方判讀卡由 gpt-dict 證據引擎 14 層 sub-agent 並行驗證後產出： L1 種子資料庫； L2 PubMed 系統性回顧； L4a–e FDA / EFSA / NHS / TFDA / WHO 監管立場； L5a–e NIH ODS / Mayo / Cleveland / Harvard / 專業學會臨床立場； L9 藥物交互； L10a–b 台灣市場與法規； L11 AI 獨立評分。
層間發現衝突會自動觸發 HEC 規則，evidence_trace 內含完整決策路徑。 每條 verbatim quote 均含原始 URL。